Welcome back to the PharmTech Weekly Roundup! I’m Susan Haigney, lead editor of PharmTech. There were some strategic investments made by industry this week, and FDA called out misleading claims about ...

Harry G. Brittain, PhD, is the director of the Center for Pharmaceutical Physics and a member of Pharmaceutical Technology 's editorial advisory board. 10 Charles Rd., Milford, NJ 08848, tel.

Norgine invests £23 million in Wales site to modernize production and boost resilience for UK and European medicine supply chains.

FDA enforcement accelerated, with recent warning-letter volume exceeding the prior decade’s total, signaling a sustained departure from historical, reactive promotional oversight. “Sameness” ...

AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

Co-legislators in Europe have reached a provisional agreement on a new pharmaceutical policy framework to help boost competitiveness, innovation, and supply chain security.

AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...